Subscribe to RSS
DOI: 10.1055/a-1897-7362
Digitale Biomarker
Einsatz von Digitalisierung und Daten bei infantiler Zerebralparese und EpilepsieDigital biomarkersUse of digitalization and data in infantile cerebral palsy and epilepsy
ZUSAMMENFASSUNG
Daten fungieren vermehrt als eine Art „neues Blut“. Sie können für die Versorgung und Forschung relevante Informationen in Form von Mustern enthalten, welche mithilfe von Algorithmen erschlossen werden. Dieser Beitrag formuliert praktische Rahmenbedingungen für „Digitale Biomarker“, also das Zusammenspiel von Algorithmen und Gesundheitsdaten zur Extraktion von objektiven Parametern zur fachlichen Beurteilung. Anhand zweier Projekte zu den Indikationen der Epilepsie und der infantilen Zerebralparese werden die Einsatzbereiche sowie die erzielten Ergebnisse beschrieben.
ABSTRACT
Data is increasingly acting as a kind of “new blood”. It can contain relevant information for medical care and research in the form of patterns, which can be extracted with the help of algorithms. This article formulates practical conditions for so-called “digital biomarkers”, i. e. the interaction of algorithms and health data to extract objective parameters for professional assessment. Based on two projects on the indications of epilepsy and infantile cerebral palsy, the areas of application and the results achieved are described.
Publication History
Article published online:
14 October 2022
© 2022. Thieme. All rights reserved.
© Georg Thieme Verlag KG Stuttgart · New York
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Amft O, Favela J, Intille S. et al Personalized Pervasive Health. IEEE Pervasive Comput 2020; 19: 11-13
- 2 Babrak LM, Menetski J, Rebhan M. et al Traditional and Digital Biomarkers: Two Worlds Apart? Digit Biomark. 2019 DOI: 10.1159/000502000
- 3 Bahcall O. Precision medicine. Nature 2015; 526: 335
- 4 Dorsey ER.. A Digital Journal for a Digital Era. Digit Biomark. 2017 DOI: 10.1159/000458512
- 5 Dorsey ER, Papapetropoulos S, Xiong M. et al The First Frontier: Digital Biomarkers for Neurodegenerative Disorders. Digit Biomark 2017 DOI: 10.1159/000477383
- 6 Elger CE, Hoppe C. Diagnostic challenges in epilepsy: seizure under-reporting and seizure detection. The Lancet Neurology 2018; 17: 279-288
- 7 Fiege E, Houta S, Bisgin P. et al Automatic Seizure Detection Using the Pulse Transit Time. 2021
- 8 Flores M, Glusman G, Brogaard K. et al P4 medicine: how systems medicine will transform the healthcare sector and society. Per Med 2013; 10: 565-576
- 9 Hellwig A, Buschmann K, Burmann A.. Designing digital games for people with cerebral palsy – a qualitative approach on fostering self-efficacy and therapy compliance. In: IEEE 8th International Conference on Serious Games and Applications for Health (SeGAH) 2020
- 10 Houta S, Bisgin P, Dulich P. Machine Learning Methods for Detection of Epileptic Seizures with Long-Term Wearable Devices. eTELEMED 2019: 108-113
- 11 Johnson KB, Wei W-Q, Weeraratne D. et al Precision Medicine, AI, and the Future of Personalized Health Care. Clin Transl Sci 2020 DOI: 10.1111/cts.12884
- 12 Kourtis LC, Regele OB, Wright JM. et al Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity. NPJ Digit Med 2019 DOI: 10.1038/s41746-019-0084-2
- 13 Meister S.. Digitale Biomarker. Health & Care Management 2019 www.hcm-magazin.de/digitale-biomarker/150/31919/387992
- 14 Meister S, Deiters W, Becker S. Digital Health and Digital Biomarkers – Enabling Value Chains on Health Data. Current Directions in Biomedical Engineering 2016; 02: 577-581
- 15 Meister S, Deiters W, Becker S. et al Pervasive Sensing and Analysis: mHealth and its need for Information Logistics Solutions. 6th International Workshop on Intelligent Environments Supporting Healthcare and Well-being. Eindhoven 2014
- 16 Meister S, Haßfeld S, Burmann A. Digitalisierung in der Mund-, Kiefer- und Gesichtschirurgie. MKG-Chirurg 2020: 1-7
- 17 Meister S, Houta S, Bisgin P.. Mobile Health und digitale Biomarker: Daten als „neues Blut“ für die P4-Medizin bei Parkinson und Epilepsie. In: Pfannstiel MA, et al. (Hrsg.) mHealth-Anwendungen für chronisch Kranke. Trends, entwicklungen. Wiesbaden: Gabler; 2020: 213-233
- 18 National Institutes of Health Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95
- 19 Ryan JM, Cassidy EE, Noorduyn SG. et al Exercise interventions for cerebral palsy. Cochrane Database Syst Rev 2017 DOI: 10.1002/14651858.CD011660.pub2
- 20 Shah VV, McNames J, Mancini M. et al Digital Biomarkers of Mobility in Parkinson’s Disease During Daily Living. J Parkinsons Dis 2020; 10: 1099-1111
- 21 Wang T, Azad T, Rajan R.. The Emerging Influence of Digital Biomarkers on Healthcare. 2019 https://rockhealth.com/reports/the-emerging-influence-of-digital-biomarkers-on-healthcare/